# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.wsj.com/health/pharma/pfizer-covid-vaccine-2020-election-probe-2f3ec247
Exelixis' Cabometyx gains FDA approval for advanced neuroendocrine tumors, while phase 3 data confirms sustained survival b...
https://www.nytimes.com/2025/03/26/health/usaid-c
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi a...
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, wi...
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highli...
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...
HHS is considering major cuts to federal HIV prevention funding as part of a CDC reorganization, potentially affecting programs...